LESLIE PEMBERTON: Open Payments
NPI 1003311036 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 33 payments from 8 companies in 2025. Trend: 2023 $214 · 2024 $885 · 2025 $714
Food & beverage: $671Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $181 |
| Galderma Laboratories, L.P. | 3 | $173 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| UCB, Inc. | 4 | $90 |
| LEO Pharma Inc. | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| ConvaTec Inc. | 1 | $14 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, COSENTYX, Rhapsido, DUPIXENT, ANZUPGO, ADBRY.
Industry payments across KY — which companies pay providers there.
